Hält derzeit Positionen bei Regulus Therapeutics Inc, Biogen Inc and Exelixis Inc
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Regulus Therapeutics Inc | 11. Juni 2013 - |
Independent Chairman of the Board | Biogen Inc | 1. Juni 2014 - |
Independent Chairman of the Board, Co-Founder | Exelixis Inc | 1. Januar 1998 - |
Independent Director | Biogen Inc | 1. Juli 2008 - 1. Juni 2014 |
Independent Director | Regulus Therapeutics Inc | 2. Januar 2009 - 11. Juni 2013 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2022-02-24 | 2022-02-22 |
Exelixis Inc
(EXEL)
|
V Verkauf |
84.515
-6.5%
19,561.653.113 USD |
84.515 -6.5% | 19,56 | 1.653.113 USD | |
2021-05-13 | 2021-05-11 |
Exelixis Inc
(EXEL)
|
V Verkauf |
5.473
-0.4%
25,01136.880 USD |
5.473 -0.4% | 25,01 | 136.880 USD | |
2021-05-13 | 2021-05-11 |
Exelixis Inc
(EXEL)
|
V Verkauf |
5.075
-0.4%
25,00126.875 USD |
5.075 -0.4% | 25,00 | 126.875 USD | |
2021-05-13 | 2021-05-11 |
Exelixis Inc
(EXEL)
|
V Verkauf |
10.222
-0.8%
24,95255.039 USD |
10.222 -0.8% | 24,95 | 255.039 USD | |
2020-05-08 | 2020-05-08 |
Exelixis Inc
(EXEL)
|
V Verkauf |
45.000
-4.1%
25,841.162.800 USD |
45.000 -4.1% | 25,84 | 1.162.800 USD | |
2019-05-08 | 2019-05-07 |
Regulus Therapeutics Inc
(RGLS)
|
K Kauf |
370.370
+45.2%
1,08400.000 USD |
370.370 +45.2% | 1,08 | 400.000 USD | |
2019-02-22 | 2019-02-21 |
Exelixis Inc
(EXEL)
|
V Verkauf |
26.250
-2.5%
21,25557.813 USD |
26.250 -2.5% | 21,25 | 557.813 USD | |
2019-01-02 | 2018-12-28 |
Regulus Therapeutics Inc
(RGLS)
|
K Kauf |
50.000
+6.4%
1,0954.570 USD |
50.000 +6.4% | 1,09 | 54.570 USD | |
2018-12-28 | 2018-12-26 |
Regulus Therapeutics Inc
(RGLS)
|
K Kauf |
90.000
+13.5%
0,9585.878 USD |
90.000 +13.5% | 0,95 | 85.878 USD | |
2017-07-25 | 2017-07-25 |
Regulus Therapeutics Inc
(RGLS)
|
K Kauf |
1.000.000
+129.8%
0,91910.000 USD |
1.000.000 +129.8% | 0,91 | 910.000 USD | |
2017-03-23 | 2017-03-21 |
Regulus Therapeutics Inc
(RGLS)
|
K Kauf |
200.000
+99.7%
1,20239.800 USD |
200.000 +99.7% | 1,20 | 239.800 USD |